Synopsis of recent research by authors named "Xiuying Mu"
- Xiuying Mu's recent research focuses on the interplay between chronic viral infections, particularly hepatitis B virus (HBV), and acute-on-chronic liver failure (ACLF), assessing outcomes like hepatocellular carcinoma incidence and immune response dynamics.
- Findings from a prospective cohort study suggest that patients recovering from acute-on-chronic liver failure due to HBV showed a lower incidence of hepatocellular carcinoma, and a reduction in natural killer (NK) cells correlates with poor outcomes in HBV-related ACLF patients.
- Mu's investigations also address immune markers in various liver conditions, highlighting the prognostic potential of serum Golgi protein 73 in alcohol-associated liver disease, low platelet counts in hepatitis E virus-related liver failure, and the role of granulocyte colony-stimulating factor in promoting recovery in ACLF patients.
